Literature DB >> 19561105

Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Simon Metenou1, Benoit Dembélé, Siaka Konate, Housseini Dolo, Siaka Y Coulibaly, Yaya I Coulibaly, Abdallah A Diallo, Lamine Soumaoro, Michel E Coulibaly, Dramane Sanogo, Salif S Doumbia, Marissa Wagner, Sekou F Traoré, Amy Klion, Siddhartha Mahanty, Thomas B Nutman.   

Abstract

The effect of filarial infections on malaria-specific immune responses was investigated in Malian villages coendemic for filariasis (Fil) and malaria. Cytokines were measured from plasma and Ag-stimulated whole blood from individuals with Wuchereria bancrofti and/or Mansonella perstans infections (Fil(+); n = 19) and those without evidence of filarial infection (Fil(-); n = 19). Plasma levels of IL-10 (geometric mean [GM], 22.8 vs 10.4) were higher in Fil(+) compared with Fil(-), whereas levels of IFN-inducible protein (IP)-10 were lower in Fil(+) (GM, 66.3 vs 110.0). Fil(+) had higher levels of spontaneously secreted IL-10 (GM, 59.3 vs 6.8 pg/ml) and lower levels of IL-2 (1.0 vs 1.2 pg/ml) than did Fil(-). Although there were no differences in levels of Staphylococcus aureus enterotoxin B-induced cytokines between the two groups, Fil(+) mounted lower IL-12p70 (GM, 1.11 vs 3.83 pg/ml; p = 0.007), IFN-gamma (GM, 5.44 vs 23.41 pg/ml; p = 0.009), and IP-10 (GM, 29.43 vs 281.7 pg/ml; p = 0.007) responses following malaria Ag (MalAg) stimulation compared with Fil(-). In contrast, Fil(+) individuals had a higher MalAg-specific IL-10 response (GM, 7318 pg/ml vs 3029 pg/ml; p = 0.006) compared with those without filarial infection. Neutralizing Ab to IL-10 (but not to TGFbeta) reversed the down-regulated MalAg-specific IFN-gamma and IP-10 (p < 0.001) responses in Fil(+). Together, these data demonstrate that filarial infections modulate the Plasmodium falciparum-specific IL-12p70/IFN-gamma secretion pathways known to play a key role in resistance to malaria and that they do so in an IL-10-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561105      PMCID: PMC2789677          DOI: 10.4049/jimmunol.0900257

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Authors:  Daniel Elias; Sven Britton; Abraham Aseffa; Howard Engers; Hannah Akuffo
Journal:  Vaccine       Date:  2008-05-21       Impact factor: 3.641

2.  Malarial anaemia in African children associated with high oxygen-radical production.

Authors:  B Greve; P G Kremsner; B Lell; D Luckner; D Schmid
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

3.  Ascaris lumbricoides infection is associated with protection from cerebral malaria.

Authors:  M Nacher; F Gay; P Singhasivanon; S Krudsood; S Treeprasertsuk; D Mazier; I Vouldoukis; S Looareesuwan
Journal:  Parasite Immunol       Date:  2000-03       Impact factor: 2.280

4.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

5.  Confirmation of the protective effect of Ascaris lumbricoides on Plasmodium falciparum infection: results of a randomized trial in Madagascar.

Authors:  Laurent Brutus; Laurence Watier; Virginie Hanitrasoamampionona; Hélène Razanatsoarilala; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

Review 6.  Renal failure in malaria.

Authors:  B S Das
Journal:  J Vector Borne Dis       Date:  2008-06       Impact factor: 1.688

7.  Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain.

Authors:  Syarifah Hanum P; Masashi Hayano; Somei Kojima
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

8.  Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.

Authors:  Marthe C D'Ombrain; Leanne J Robinson; Danielle I Stanisic; Jack Taraika; Nicholas Bernard; Pascal Michon; Ivo Mueller; Louis Schofield
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

9.  Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast.

Authors:  Ephantus J Muturi; Charles M Mbogo; Joseph M Mwangangi; Zipporah W Ng'ang'a; Ephantus W Kabiru; Charles Mwandawiro; John C Beier
Journal:  Filaria J       Date:  2006-05-24

10.  Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal.

Authors:  Cheikh Sokhna; Jean-Yves Le Hesran; Pape A Mbaye; Jean Akiana; Pape Camara; Mamadou Diop; Abdoulaye Ly; Pierre Druilhe
Journal:  Malar J       Date:  2004-11-15       Impact factor: 2.979

View more
  40 in total

1.  At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells.

Authors:  Simon Metenou; Benoit Dembele; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Sekou F Traoré; Siddhartha Mahanty; Amy Klion; Thomas B Nutman
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

Review 2.  Parasite virulence, co-infections and cytokine balance in malaria.

Authors:  Raquel Müller Gonçalves; Nathália Ferreira Lima; Marcelo Urbano Ferreira
Journal:  Pathog Glob Health       Date:  2014-05-23       Impact factor: 2.894

3.  Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen-driven IL-12 and IFN-γ in filaria-malaria co-infection.

Authors:  Simon Metenou; Michael Kovacs; Benoit Dembele; Yaya I Coulibaly; Amy D Klion; Thomas B Nutman
Journal:  Eur J Immunol       Date:  2012-01-19       Impact factor: 5.532

4.  Helminth infection alters IgE responses to allergens structurally related to parasite proteins.

Authors:  Helton da Costa Santiago; Flávia L Ribeiro-Gomes; Sasisekhar Bennuru; Thomas B Nutman
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

Review 5.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  Malaria, erythrocytic infection, and anemia.

Authors:  Kasturi Haldar; Narla Mohandas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 7.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

8.  Towards a precise test for malaria diagnosis in the Brazilian Amazon: comparison among field microscopy, a rapid diagnostic test, nested PCR, and a computational expert system based on artificial neural networks.

Authors:  Bruno B Andrade; Antonio Reis-Filho; Austeclino M Barros; Sebastião M Souza-Neto; Lucas L Nogueira; Kiyoshi F Fukutani; Erney P Camargo; Luís M A Camargo; Aldina Barral; Angelo Duarte; Manoel Barral-Netto
Journal:  Malar J       Date:  2010-05-06       Impact factor: 2.979

9.  Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).

Authors:  Vivekanandhan Aravindhan; Viswanathan Mohan; Jayagopi Surendar; Maradana Muralidhara Rao; Nathella Pavankumar; Mohan Deepa; Ramanujam Rajagopalan; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

Review 10.  Regulation of pathogenesis and immunity in helminth infections.

Authors:  Rick M Maizels; Edward J Pearce; David Artis; Maria Yazdanbakhsh; Thomas A Wynn
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.